title: Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.
abstract: The mechanism by which mutations in the presenilin (PS) genes cause the most aggressive form of early-onset Alzheimer's disease (AD) is unknown, but fibroblasts from mutation carriers secrete increased levels of the amyloidogenic A beta 42 peptide, the main component of AD plaques. We established transfected cell and transgenic mouse models that coexpress human PS and amyloid beta-protein precursor (APP) genes and analyzed quantitatively the effects of PS expression on APP processing. In both models, expression of wild-type PS genes did not alter APP levels, alpha- and beta-secretase activity and A beta production. In the transfected cells, PS1 and PS2 mutations caused a highly significant increase in A beta 42 secretion in all mutant clones. Likewise, mutant but not wildtype PS1 transgenic mice showed significant overproduction of A beta 42 in the brain, and this effect was detectable as early as 2-4 months of age. Different PS mutations had differential effects on A beta generation. The extent of A beta 42 increase did not correlate with presenilin expression levels. Our data demonstrate that the presenilin mutations cause a dominant gain of function and may induce AD by enhancing A beta 42 production, thus promoting cerebral beta-amyloidosis.
authors.affiliation: Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
authors.forename: M
authors.initials: M
authors.lastname: Citron
authors.forename: D
authors.initials: D
authors.lastname: Westaway
authors.forename: W
authors.initials: W
authors.lastname: Xia
authors.forename: G
authors.initials: G
authors.lastname: Carlson
authors.forename: T
authors.initials: T
authors.lastname: Diehl
authors.forename: G
authors.initials: G
authors.lastname: Levesque
authors.forename: K
authors.initials: K
authors.lastname: Johnson-Wood
authors.forename: M
authors.initials: M
authors.lastname: Lee
authors.forename: P
authors.initials: P
authors.lastname: Seubert
authors.forename: A
authors.initials: A
authors.lastname: Davis
authors.forename: D
authors.initials: D
authors.lastname: Kholodenko
authors.forename: R
authors.initials: R
authors.lastname: Motter
authors.forename: R
authors.initials: R
authors.lastname: Sherrington
authors.forename: B
authors.initials: B
authors.lastname: Perry
authors.forename: H
authors.initials: H
authors.lastname: Yao
authors.forename: R
authors.initials: R
authors.lastname: Strome
authors.forename: I
authors.initials: I
authors.lastname: Lieberburg
authors.forename: J
authors.initials: J
authors.lastname: Rommens
authors.forename: S
authors.initials: S
authors.lastname: Kim
authors.forename: D
authors.initials: D
authors.lastname: Schenk
authors.forename: P
authors.initials: P
authors.lastname: Fraser
authors.forename: P
authors.initials: P
authors.lastname: St George Hyslop
authors.forename: D J
authors.initials: DJ
authors.lastname: Selkoe
mesh_terms: D000544:Alzheimer Disease / Q000235:genetics*; D016229:Amyloid beta-Peptides / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D016564:Amyloid beta-Protein Precursor / Q000235:genetics / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism / Q000473:pathology; D002460:Cell Line; D004797:Enzyme-Linked Immunosorbent Assay; D005822:Genetic Vectors; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D010446:Peptide Fragments / Q000235:genetics / Q000378:metabolism; D053764:Presenilin-1; D053766:Presenilin-2; D014162:Transfection
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D008565:Membrane Proteins; C508853:PSEN1 protein, human; C508861:PSEN2 protein, human; D010446:Peptide Fragments; D053764:Presenilin-1; D053766:Presenilin-2